Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Ravuconazole is a new antifungal triazole with broad-spectrum activity and a long half-life in plasma. We studied the antifungal efficacy, safety, and pharmacokinetics of ravuconazole lysine phosphoester in escalating dosages for the treatment of invasive pulmonary aspergillosis due to Aspergillus f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Petraitiene, Ruta, Petraitis, Vidmantas, Lyman, Caron A., Groll, Andreas H., Mickiene, Diana, Peter, Joanne, Bacher, John, Roussillon, Kristin, Hemmings, Melissa, Armstrong, Derrek, Avila, Nilo A., Walsh, Thomas J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2004
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC375262/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15047519/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.4.1188-1196.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados